Bile Duct Cancer Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 19thDecember 2014

Summary
The industry analysis specialist, has released its new report, Bile Duct Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Bile Duct Cancer Therapeutics market. The report
identifies the key trends shaping and driving the global Bile Duct Cancer Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging
players expected to significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline products within the
global Bile Duct Cancer Therapeutics sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by
GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-bile-duct-cancer-therapeutics-pipeline-assessment-and-marketforecasts-135240

Scope
The report provides information on the key drivers and challenges of the Bile Duct Cancer
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Bile Duct
Cancer Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Bile Duct Cancer
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Bile Duct Cancer Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Bile Duct Cancer Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Bile
Duct Cancer Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Bile Duct Cancer Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Bile Duct Cancer Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Bile Duct Cancer Therapeutics - Introduction
2.1 Overview
2.2 Classification of Bile Duct Cancer
2.3 Epidemiology
2.4 Etiology
2.5 Pathophysiology
2.6 Signs and Symptoms
2.7 Diagnosis
2.7.1 Physical Exam and History
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.7.2 Blood Tests

2.7.3 Diagnostic Imaging Techniques
2.7.4 Other tests
2.8 Staging
2.8.1 TNM Classification
2.9 Treatment
2.9.1 Surgery
2.9.2 Chemotherapy
2.9.3 Radiation Therapy (RT)
2.10 Chemotherapy Regimens
2.11 GlobalData Pipeline Report Guidance
3 Bile Duct Cancer Therapeutics - Market Characterization
3.1 Bile Duct Cancer Therapeutics Market Size (2006-2011) Global
3.2 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) Global
3.3 Bile Duct Cancer Therapeutics Market Size (2006-2011) US
3.4 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) The US
3.5 Bile Duct Cancer Therapeutics Market Size (2006-2011) The UK
3.6 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) The UK
3.7 Bile Duct Cancer Therapeutics Market Size (2006-2011) France
3.8 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) France
3.9 Bile Duct Cancer Therapeutics Market Size (2006-2011) Germany
3.10 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) Germany
3.11 Bile Duct Cancer Therapeutics Market Size (2006-2011) Italy
3.12 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) Italy
3.13 Bile Duct Cancer Therapeutics Market Size (2006-2011) Spain
3.14 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) Spain
3.15 Bile Duct Cancer Therapeutics Market Size (2006-2011) Japan
3.16 Bile Duct Cancer Therapeutics Market Forecast (2011-2019) Japan
3.17 Drivers and Barriers for the Bile Duct Cancer Therapeutics Market
3.17.1 Drivers for the Bile Duct Cancer Therapeutics Market
3.17.2 Barriers for the Bile Duct Cancer Therapeutics Market
3.18 Key Events Impacting the Future Market
3.18.1 Opportunity and Unmet Need
3.19 Key Takeaway
4 Bile Duct Cancer Therapeutics Market - Competitive Assessment
4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Profiles of the Commonly Used Products in the Bile Duct Cancer Therapeutics Market
4.2.1 Gemcitabine
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4.2.2 Gemcitabine and Oxaliplatin (GEMOX)

4.2.3 Gemcitabine and Cisplatin
4.2.4 Gemcitabine and Capecitabine
4.3 Key Takeaway
5 Bile Duct Cancer Therapeutics Market - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Bile Duct Cancer Pipeline Analysis Pipeline by Clinical Phases of Development
5.3.1 Bile Duct Cancer Therapeutics Phase III Pipeline
5.3.2 Bile Duct Cancer Therapeutics Phase II Pipeline
5.3.3 Bile Duct Cancer Therapeutics Phase I/II Pipeline
5.3.4 Bile Duct Cancer Therapeutics Phase I Pipeline
5.3.5 Bile Duct Cancer Therapeutics Preclinical Pipeline
5.4 Bile Duct Cancer Pipeline by Mechanism of Action
5.5 Bile Duct Cancer Technology Trends Analytical Framework
5.6 Molecule Profile for Selected Drugs under Clinical Development
5.6.1 Caprelsa (vandetanib)
5.6.2 OTS102 (elpamotide)
5.6.3 S-1 (tegafur, gimeracil and oteracil)
5.7 Key Takeaway
6 Bile Duct Cancer Therapeutics Clinical Trials Mapping
6.1 Clinical Trials by Country (US, EU5 and Japan)
6.2 Clinical Trials Mapping by Phase
6.3 Clinical Trials Mapping by Trial Status
6.4 Overall Sponsors
6.5 Prominent Sponsors
6.6 Top Companies Participating in Bile Duct Cancer Therapeutics Clinical Trials
7 Bile Duct Cancer Therapeutics - Strategic Assessment
7.1 Future Market Competition Scenario
8 Bile Duct Cancer Therapeutics - Future Players in The Market
8.1 Introduction
8.2 Company Profiles
8.2.1 AstraZeneca PLC
8.2.2 Otsuka Pharmaceutical Co. Ltd. (OPC)
9 Bile Duct Cancer Therapeutics - Licensing and Partnership Deals
10 Bile Duct Cancer Therapeutics - Appendix
10.1 Definitions
10.2 Acronyms
10.3 Methodology
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: Survival Rates of Bile Duct Cancer
Table 2: Prevalence of Bile Duct Cancer in Major Markets
Table 3: Intrahepatic Bile Duct Cancer, TNM Definitions
Table 4: Intrahepatic Bile Duct Cancer, Stage Grouping
Table 5: Perihilar Bile Duct Cancer, TNM Definitions
Table 6: Perihilar Bile Duct Cancer, Stage Grouping
Table 7: Distal Bile Duct Cancer, TNM Definitions
Table 8: Distal Bile Duct Cancer, Stage Grouping
Table 9: Bile Duct Cancer Chemotherapy regimens
Table 10: Bile Duct Cancer Therapeutics Market, Global, Revenue ($m), 20062011
Table 11: Bile Duct Cancer Therapeutics Market, Global, Forecast ($m), 20112019
Table 12: Bile Duct Cancer Therapeutics Market, The US, Revenue ($m), 20062011
Table 13: Bile Duct Cancer Therapeutics Market, The US, Revenue ($m), 20112019
Table 14: Bile Duct Cancer Therapeutics Market, The UK, Revenue ($m), 20062011
Table 15: Bile Duct Cancer Therapeutics Market, The UK, Forecast ($m), 20112019
Table 16: Bile Duct Cancer Therapeutics Market, France, Revenue ($m), 20062011
Table 17: Bile Duct Cancer Therapeutics Market, France, Forecast ($m), 20112019
Table 18: Bile Duct Cancer Therapeutics Market, Germany, Revenue ($m), 20062011
Table 19: Bile Duct Cancer Therapeutics Market, Germany, Forecast ($m), 20112019
Table 20: Bile Duct Cancer Therapeutics Market, Italy, Revenue ($m), 20062011
Table 21: Bile Duct Cancer Therapeutics Market, Italy, Forecast ($m), 20112019
Table 22: Bile Duct Cancer Therapeutics Market, Spain, Revenue ($m), 20062011
Table 23: Bile Duct Cancer Therapeutics Market, Spain, Forecast ($m), 20112019
Table 24: Bile Duct Cancer Therapeutics Market, Japan, Revenue ($m), 20062011
Table 25: Bile Duct Cancer Therapeutics Market, Japan, Forecast ($m), 20112019
Table 26: Bile Duct Cancer Therapeutics Phase III Pipeline
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 27: Bile Duct Cancer Therapeutics Phase II Pipeline

Table 28: Bile Duct Cancer Therapeutics Phase I/II Pipeline
Table 29: Bile Duct Cancer Therapeutics Phase I Pipeline
Table 30: Bile Duct Cancer Therapeutics Preclinical Pipeline
Table 31: Bile Duct Cancer Therapeutics Clinical Trials by Country, 2011
Table 32: Bile Duct Cancer Therapeutics Clinical Trials by Phase, 2011
Table 33: Bile Duct Cancer Therapeutics Clinical Trials by Status, 2011
Table 34: Bile Duct Cancer Therapeutics - Clinical Trials by Overall Sponsors, 2011
Table 35: Bile Duct Cancer Therapeutics Clinical Trials by Prominent Sponsors, 2011
Table 36: Bile Duct Cancer Therapeutics Clinical Trial - Company Sponsors by Phase, 2011
Table 37: AstraZeneca Bile Duct Cancer Pipeline
Table 38: Otsuka Pharmaceutical Co. Ltd Bile Duct Cancer Pipeline
Table 39: OA Therapeutics: Licensing and Partnership Deals

List Of Figures
Figure 1: Anatomy of the Bile Duct
Figure 2: Classification of Bile Duct Cancer
Figure 3: Anatomy of the Intrahepatic and Extrahepatic Bile Duct
Figure 4: Endoscopic Retrograde Cholangiopancreatography (ERCP)
Figure 5: Percutaneous Transhepatic Cholangiography (PTC)
Figure 6: Bile Duct Cancer Therapeutics Market, Global, Revenue ($m), 20062011
Figure 7: Bile Duct Cancer Therapeutics, Market Share ($m), 2011
Figure 8: Bile Duct Cancer Therapeutics Market, Global, Forecast ($m), 20112019
Figure 9: Bile Duct Cancer Therapeutics, Market Share ($m), 2019
Figure 10: Bile Duct Cancer Therapeutics Market, The US, Revenue ($m), 20062011
Figure 11: Bile Duct Cancer Therapeutics Market, The US, Forecast ($m), 20112019
Figure 12: Bile Duct Cancer Therapeutics Market, The UK, Revenue ($m), 20062011
Figure 13: Bile Duct Cancer Therapeutics, The UK, Forecast ($m), 20112019
Figure 14: Bile Duct Cancer Therapeutics Market, France, Revenue ($m), 20062011
Figure 15: Bile Duct Cancer Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 16: Bile Duct Cancer Therapeutics Market, Germany, Revenue ($m), 20062011
Figure 17: Bile Duct Cancer Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 18: Bile Duct Cancer Therapeutics Market, Italy, Revenue ($m), 20062011
Figure 19: Bile Duct Cancer Therapeutics Market, Italy, Forecast ($m), 20112019
Figure 20: Bile Duct Cancer Therapeutics Market, Spain, Revenue ($m), 20062011
Figure 21: Bile Duct Cancer Therapeutics Market, Spain, Forecast ($m), 20112019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 22: Bile Duct Cancer Therapeutics Market, Japan, Revenue ($m), 20062011
Figure 23: Bile Duct Cancer Therapeutics Market, Japan, Forecast ($m), 20112019
Figure 24: Bile Duct Cancer Therapeutics, Key Events Impacting the Future Market, 2011
Figure 25: Opportunity and Unmet Need in the Bile Duct Cancer Therapeutics Market, 2011
Figure 26: Bile Duct Cancer Therapeutics Market Strategic Competitor Assessment, 2011
Figure 27: Bile Duct Cancer Therapeutics - Pipeline by Phase of Clinical Development, 2011
Figure 28: Bile Duct Cancer Therapeutics Clinical Pipeline by Mechanism Of Action, 2011
Figure 29: Bile Duct Cancer Therapeutics - Technology Trends Analytical Framework, 2011
Figure 30: Bile Duct Cancer Therapeutics - Technology Trends Analytical Framework
Description, 2011
Figure 31: Bile Duct Cancer Therapeutics Clinical Trials by Country, 2011
Figure 32: Bile Duct Cancer Therapeutics Clinical Trials by Phase, 2011
Figure 33: Bile Duct Cancer Therapeutics Clinical Trials by Status, 2011
Figure 34: Bile Duct Cancer Therapeutics Clinical Trials by Overall Sponsors, 2011
Figure 35: Bile Duct Cancer Therapeutics Clinical Trials by Prominent Sponsors, 2011
Figure 36: Bile Duct Cancer Therapeutics Clinical Trial - Company Sponsors by Phase, 2011
Figure 37: Bile Duct Cancer Therapeutics, Strategic Assessment, 2011
Figure 38: Bile Duct Cancer Therapeutics Market Clinical Pipeline by Company, 2011
Figure 39: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market
Forecasts to 2018
Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018
Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts
to 2019
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Athletes Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

To know more on Bile Duct Cancer Therapeutics - Pipeline Assessment and

Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-bile-duct-cancertherapeutics-pipeline-assessment-and-market-forecasts-135240

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/